The European Society of Cardiology (ESC) together with other partner Societies has engaged in a comprehensive programme of CVD prevention in clinical practice since 1994. Guidelines on this important topic have been developed and updated at regular intervals over the last 30 years: 1994, 1998, 2003, 2007, 2012, 2016 and 2021. Guideline implementation in Europe has been evaluated in cross-sectional surveys with the acronym EUROASPIRE over the same timeframe: 1995, 1999,2006,2012,2016, 2024. Data are collected from patients with a history of CHD in the hospital arm and those at high risk if developing CVD in the primary care arm.

The objective of the Euroaspire survey was to determine whether clinical practice in patients with coronary heart disease (CHD) and people at high risk of developing CVD was achieving the standards set in the CVD prevention guidelines and whether there were any changes over time in lifestyle, risk factor and therapeutic management. Later surveys have and incorporated an assessment of dysglycaemia and renal disease.

Results of the EUROASPIRE V survey clearly demonstrate that most of coronary and high CVD risk patients are failing to achieve the lifestyle, blood pressure, lipid and glycaemic targets as defined in the 2016 JES Guidelines on CVD prevention in clinical practice. A wide gap still exists between the evidence-based guidelines and everyday clinical practice in Europe.

The latest survey EUROASPIRE IV is currently underway in the hospital arm with 27 countries recruiting patients; the primary care arm is due to commence in 16 countries.

Participating Countries

Euroaspire VI Participating Countries:

I. Hospital arm: Bosnia & Herzegovina, Bulgaria, Croatia, The Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, the Netherlands, Poland, Portugal, Romania, Serbia, Slovenia, Spain, Sweden, Turkey, Ukraine, the United Kingdom and Uzbekistan.

II. Primary care arm: To be determined.

Steering Committee

Executive Committee
  • Prof John William McEvoy (Co-Principal Investigator, Galway, Ireland)
  • Prof David Wood (Co-Principal Investigator, London, UK)
  • Prof Kornelia Kotseva (London, UK, Chair Steering Committee)
  • Prof Catriona Sian Jennings
  • Prof Dirk De Bacquer
  • Prof Kausik K Ray
  • Prof Lars Ryden
  • Prof Per-Henrik Groop
  • Prof Linda Mellbin
  • Dr Iris Erlund
  • Dr Terhi Vihervaara
  • Dr Sandra Ganly
  • Agnieszka Adamska
National Coordinators 
  • Bosnia & Herzegovina – Dusko Vulic, Mirza Dilic  
  • Bulgaria – Elena Dimitrova  
  • Croatia – Zeljko Reiner, Davor Milicic  
  • The Czech Republic – Jan Bruthans, Renata Cifkova
  • Finland – Seppo Lehto  
  • France – Victor Aboyans  
  • Germany – Peter Heuschmann, Stefan Stork  
  • Greece – Lampros Michalis
  • Ireland – John William McEvoy  
  • Iceland – Karl Konrao Andersen  
  • Italy – Aldo Maggioni, Furio Colivicchi 
  • Kazakhstan – Kairat Davletov  
  • Kyrgyzstan – Erkin Mirrakhimov  
  • Latvia – Andrejs Erglis, Vilnis Dzerve
  • Lithuania – Jolita Badariene, Jurgita Plisiene  
  • Poland – Piotr Jankowski, Monika Burzynska  
  • Portugal – Ana Abreu, Carlos Aguiar  
  • Romania – Iulia Kulcsar
  • Serbia – Dragan Lovic, Nebojsa Lalic  
  • Slovenia – Zlatko Fras  
  • Spain – Almudena Castro Conde  
  • Sweden – Lars Ryden  
  • The Netherlands– Maarten Leening, Fabrice Martens
  • The UK – David Wood
  • Turkey – Lale Tokgozoglu, Baris Gungor, Oner Ozdogan
  • Ukraine – Maryna Dolzhenko
  • Uzbekistan – Jamol Uzokov
Collaborators 

Coordinating Centre 

National Institute for Prevention and Cardiovascular Health: Professor J. Willian (Bill) McEvoy, Professor David Wood, Professor Catriona Sian Jennings, Professor Kornelia Kotseva, Agnieszka Adamska, Andrea Zekic, Dr Sandra Ganly, Dr Irene Gibson, Dr Susan Hennessy 

Data Management Centre 

Global Registries and Surveys Programme of the ESC, European Heart House, Sophia Antipolis, Nice, France: Emilie Sorano, Khadidiatou Diallo, Wendy Guillouche, Aurelie Bellone  

Statistical Analysis Centre 

Department of Public Health, Ghent University, Belgium: Professor Dirk De Bacquer

Diabetes Centre 

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden: Professor Lars Rydén, Professor Linda Mellbin 

Chronic Kidney Disease Centre 

University of Helsinki and Helsinki University Hospital, Finland: Professor Per-Henrik Groop​ 

Central Laboratory 

Institute for Nutrition and Health Research (NHRESE), Helsinki, Finland; Dr Iris Erlund, Dr Terhi Vihervaara, Elina Jarvensivu

Sponsors 

Daiichi Sankyo, Novartis, Novo Nordisk, Menarini, MSD, Viatris

Eurospire Publications